Search the edit
18 records in the current edit
SHA, RoseBar, Atzaró and ZEM all sell longevity. One feels close to a medical programme; another can be booked like a spa day. Here’s the real difference.
Creatine, menopause formulas, vitamin D and pregnancy supplements are everywhere. The evidence—and the rules—do not travel as a package.
UtoLife is built around a twelve-month clinical relationship. Seven Springs is closer to a private members’ club. The category is splitting in two.
The investigation closed at 131 reported cases across 38 states. Because the products last for years, that is not the same as the risk disappearing overnight.
Galaxy Watch9 and Ultra2 fold five overnight measurements into a daily baseline. The sensors matter less than what Samsung does with the interpretation.
The US beta connects wearable data, Energy Score and conversational answers. It is a glimpse of where every health dashboard is heading.
The 2026 guidance adds air pollution to a familiar mix of movement, smoking, alcohol, diet, social connection and long-term health conditions.
The July update reaches products sold for sexual enhancement, weight loss and muscle building—including formulas that may never make their real contents obvious.
A new Nature Aging study compared trained and untrained muscle to see what decades of exercise leave behind—and how older muscle still responds.
“Senescent cells” are often discussed as one target. The first large-scale atlas shows a far messier picture across tissues and stages of life.
The June update covers authorised claims, interactions and the line supplement labels cannot cross when they talk about symptoms.
A three-day residency mixed masterclasses, private sessions and a guest programme—part retreat, part live event and part access to a recognised name.
Atzaró’s menu runs from €50 cryotherapy to a €270 longevity day. It is a useful look at how the idea is being packaged by the session.
Health Radar watches for longer-term changes while lab uploads put blood results beside ring data. That brings a different kind of responsibility.
The FDA database lists the DEP100 as an aesthetic electrical stimulator. Clearance is specific; it is not a blank cheque for every beauty claim around it.
A new pilot lets selected high-risk devices get expert scientific input earlier. The wider programme is expected to expand in 2027.
Testing found DMAA, DMHA and phenibut. Only one product was voluntarily recalled, which leaves an uncomfortable gap between finding and removal.
Specific statements about cardiovascular risk, breast cancer and probable dementia have moved out of the most prominent warning box.